PCDH17 and benign prostatic hyperplasia: For example in serum samples from a Chinese cohort (MSP; early PCa n = 167; BPH n = 44) [122], PCDH17 promoter methylation was detected in 57% of PCa patients and absent in BPH patients (p < 0.001).